Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use

Author:

Chakravorty Soumitesh1,Roh Sandy S.1,Glass Jennifer2,Smith Laura E.1,Simmons Ann Marie2,Lund Kevin3,Lokhov Sergey3,Liu Xin4,Xu Peng5,Zhang Guolong67,Via Laura E.89,Shen Qingyu6,Ruan Xianglin4,Yuan Xing4,Zhu Hong Zhu6,Viazovkina Ekaterina3,Shenai Shubhada1,Rowneki Mazhgan1,Lee Jong Seok10,Barry Clifton E.89,Gao Qian5,Persing David2,Kwiatkawoski Robert2,Jones Martin2,Gall Alexander3,Alland David1

Affiliation:

1. Department of Medicine, New Jersey Medical School, Newark, New Jersey, USA

2. Cepheid Inc., Sunnyvale, California, USA

3. Cepheid Inc., Bothell, Washington, USA

4. Henan Provincial Chest Hospital, Zhengzhou, Henan Province, China

5. Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institutes of Biomedical Sciences and Institute of Medical Microbiology, School of Basic Medical Sciences, Fudan University, Shanghai, China

6. Sino-US International Research Center of Tuberculosis, Zhengzhou, China

7. Henan Public Health Clinical Center, Zhengzhou, China

8. Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA

9. Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa

10. Department of Microbiology, International Tuberculosis Research Center, Changwon, Gyeongsnag, Republic of Korea

Abstract

ABSTRACT Extensively drug-resistant (XDR) tuberculosis (TB) cannot be easily or quickly diagnosed. We developed a rapid, automated assay for the detection of XDR-TB plus resistance to the drug isoniazid (INH) for point-of-care use. Using a simple filter-based cartridge with an integrated sample processing function, the assay identified a wide selection of wild-type and mutant sequences associated with XDR-TB directly from sputum. Four new large-Stokes-shift fluorophores were developed. When these four Stokes-shift fluorophores were combined with six conventional fluorophores, 10-color probe detection in a single PCR tube was enabled. A new three-phase, double-nested PCR approach allowed robust melting temperature analysis with enhanced limits of detection (LODs). Finally, newly designed sloppy molecular beacons identified many different mutations using a small number of probes. The assay correctly distinguished wild-type sequences from 32 commonly occurring mutant sequences tested in gyrA , gyrB , katG , and rrs genes and the promoters of inhA and eis genes responsible for resistance to INH, the fluoroquinolone (FQ) drugs, amikacin (AMK), and kanamycin (KAN). The LOD was 300 CFU of Mycobacterium tuberculosis in 1 ml sputum. The rate of detection of heteroresistance by the assay was equivalent to that by Sanger sequencing. In a blind study of 24 clinical sputum samples, resistance mutations were detected in all targets with 100% sensitivity, with the specificity being 93.7 to 100%. Compared to the results of phenotypic susceptibility testing, the sensitivity of the assay was 75% for FQs and 100% each for INH, AMK, and KAN and the specificity was 100% for INH and FQ and 94% for AMK and KAN. Our approach could enable testing for XDR-TB in point-of-care settings, potentially identifying highly drug-resistant TB more quickly and simply than currently available methods.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference57 articles.

1. Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries;Bonnet M;Int J Tuberc Lung Dis,2005

2. An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa;Lin J;Int J Tuberc Lung Dis,2004

3. Drug resistance of Mycobacterium tuberculosis complex in central Taiwan;Liu CE;J Microbiol Immunol Infect,2004

4. Allele-Specific rpoB PCR Assays for Detection of Rifampin-Resistant Mycobacterium tuberculosis in Sputum Smears

5. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001-2002);Negi SS;J Commun Dis,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3